HFS
ALNY icon

Hughes Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Hughes Financial Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.33K Buy
31
+14
+82% +$4.22K ﹤0.01% 381
2026
Q1 		$5.63K Buy
17
+5
+42% +$1.7K ﹤0.01% 407
2025
Q4 		$4.77K Hold
12
– – ﹤0.01% 404
2025
Q3 		$5.3K Hold
12
– – ﹤0.01% 382
2025
Q2 		$5.14K Buy
12
+4
+50% +$1.11K ﹤0.01% 394
2025
Q1 		$2.05K Buy
+8
New +$2.06K ﹤0.01% 569

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hughes Financial Services's ALNY Position: Q2 2026 in Review

Hughes Financial Services increased its Alnylam Pharmaceuticals (ALNY) stake by 82% in Q2 2026, buying an estimated $4.22K and bringing the position to 31 shares worth $9.33K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Hughes Financial Services first reported a position in ALNY in Q1 2025 and has held it in 6 quarters since. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Hughes Financial Services held 31 shares of Alnylam Pharmaceuticals worth $9.33K as of Q2 2026.
  • Hughes Financial Services bought 14 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $4.22K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #381 holding.
  • Hughes Financial Services first reported a position in Alnylam Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.